The first clinical study of BW-234U in schizophrenia.
Publication
, Journal Article
Davidson, J; Miller, R; Wingfield, M; Zung, W; Dren, AT
Published in: Psychopharmacol Bull
October 1982
Duke Scholars
Published In
Psychopharmacol Bull
ISSN
0048-5764
Publication Date
October 1982
Volume
18
Issue
4
Start / End Page
173 / 176
Location
United States
Related Subject Headings
- Schizophrenia
- Psychiatry
- Middle Aged
- Humans
- Drug Evaluation
- Carbazoles
- Antipsychotic Agents
- Adult
- Adolescent
Citation
APA
Chicago
ICMJE
MLA
NLM
Davidson, J., Miller, R., Wingfield, M., Zung, W., & Dren, A. T. (1982). The first clinical study of BW-234U in schizophrenia. Psychopharmacol Bull, 18(4), 173–176.
Davidson, J., R. Miller, M. Wingfield, W. Zung, and A. T. Dren. “The first clinical study of BW-234U in schizophrenia.” Psychopharmacol Bull 18, no. 4 (October 1982): 173–76.
Davidson J, Miller R, Wingfield M, Zung W, Dren AT. The first clinical study of BW-234U in schizophrenia. Psychopharmacol Bull. 1982 Oct;18(4):173–6.
Davidson, J., et al. “The first clinical study of BW-234U in schizophrenia.” Psychopharmacol Bull, vol. 18, no. 4, Oct. 1982, pp. 173–76.
Davidson J, Miller R, Wingfield M, Zung W, Dren AT. The first clinical study of BW-234U in schizophrenia. Psychopharmacol Bull. 1982 Oct;18(4):173–176.
Published In
Psychopharmacol Bull
ISSN
0048-5764
Publication Date
October 1982
Volume
18
Issue
4
Start / End Page
173 / 176
Location
United States
Related Subject Headings
- Schizophrenia
- Psychiatry
- Middle Aged
- Humans
- Drug Evaluation
- Carbazoles
- Antipsychotic Agents
- Adult
- Adolescent